CBIO Crescent Biopharma, Inc. - Common Stock
$17,34
Precio · Ago 18, 2026
Fundamentales a fecha de Jul 30, 2026
Rango 52S
$9–$27
46% of range
Calificación del Analista
BUY
15 analysts
Precio Objetivo
$31
+76% upside
P/E (TTM)
-35.4
ROE
-90.0%
Margen de Beneficio Neto
-1419.6%
CBIO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$17.34
Capitalización Bursátil
$478M
P/E (TTM)
-35.4
BPA (TTM)
$-0.59
Ingresos (TTM)
$11M
Rendimiento div.
—
ROE
-90.0%
Deuda/Capital
—
Rango 52S
$9 – $27
CBIO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$11M
2016-12-31
→
2025-12-31
BPA
$-0.59
2019-12-31
→
2024-12-31
Flujo de caja libre
$-72M
2016-12-31
→
2025-12-31
Márgenes
-1419.6%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
CBIO
Mediana de Pares
P/E (TTM)
-35.4
19.6
P/S (TTM) (P/V (TTM))
44.1
6.4
P/B (P/C)
2.4
2.6
Price / FCF (Precio / FCF)
-6.6
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
CBIO
Mediana de Pares
Operating Margin (Margen Operativo)
-1407.5%
—
Net Profit Margin (Margen de Beneficio Neto)
-1419.6%
-104.2%
ROA
-111.6%
-40.3%
ROE
-90.0%
-42.4%
ROIC
-76.2%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
CBIO
Mediana de Pares
Current Ratio (Ratio corriente)
6.6
5.4
Quick Ratio (Ratio Rápido)
6.4
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
CBIO
Mediana de Pares
Revenue YoY (Ingresos interanuales)
-86.7%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
424.9%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
1.3%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
CBIO
Mediana de Pares
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
Rendimiento por Dividendo
—
Ratio de Pago
—
CAGR de Dividendos a 5 años
—
| Fecha ex-dividendo | Monto |
|---|---|
| 13 de enero de 2023 | $24,0000 |
| 21 de septiembre de 2022 | $143,0000 |
CBIO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
15 analistas
- Compra fuerte 6 40,0%
- Compra 7 46,7%
- Mantener 2 13,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
5 analistas · 2026-08-19
Mediana
$28.00
Media
$30.60
← Por Debajo de Todos los Objetivos
$17.34
Mín
$27.00
Máx
$35.00
Objetivo mediano
$28.00
+61,5%
Objetivo medio
$30.60
+76,5%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.18%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.74 | $-0.81 | 0.07% |
| 31 de marzo de 2026 | $-0.70 | $-0.97 | 0.27% |
| 31 de diciembre de 2025 | $-0.54 | $-2.57 | 2.0% |
| 30 de septiembre de 2025 | $-1.27 | $-2.02 | 0.75% |
| 30 de junio de 2025 | $-4.93 | $-1.80 | -3.1% |
| 31 de marzo de 2025 | $-4.00 | $-5.10 | 1.1% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| R&D Expense | $138M | $14M | $20M | $28M | $47M | $45M | $47M | $40M | $24M | $23M | $25M | $20M | |
| SG&A Expense | $25M | $18M | $19M | $19M | $17M | $17M | $14M | $11M | $10M | $9M | $8M | $7M | |
| Operating Expenses | $163M | $40M | $39M | $47M | $65M | $62M | $61M | $52M | $34M | $32M | $33M | $26M | |
| Operating Income | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M | |
| Other Non-op | · | $2M | $2M | · | · | · | · | · | $651.2K | $103.6K | $15.3K | $18.2K | |
| Pretax Income | $-152M | · | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| EPS (Basic) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| EPS (Diluted) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| Shares (Basic) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| Shares (Diluted) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| EBITDA | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $213M | $35M | $42M | $48M | $90M | $137M | $158M | $210M | $124M | $40M | $47M | $55M | |
| Receivables | $18M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $5M | $38.0K | $2M | $3M | $533.8K | $1M | $4M | $2M | $3M | $478.5K | $441.8K | $916.2K | |
| Other Current Assets | $5M | $38.0K | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $237M | $35M | $44M | $51M | $91M | $138M | $163M | $212M | $127M | $41M | $47M | $56M | |
| PP&E (Net) | $846.0K | $0 | · | $242.4K | $368.8K | $620.7K | $822.9K | $957.2K | $1M | $1M | $521.4K | $452.3K | |
| PP&E (Gross) | · | · | · | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | |
| Accum. Depreciation | · | · | · | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $902.1K | $905.5K | |
| Other Non-current Assets | $1M | $813.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Accounts Payable | · | $329.3K | $868.1K | $970.2K | $2M | $2M | $1M | $3M | $3M | $2M | $564.2K | $874.0K | |
| Accrued Liabilities | $16M | $2M | $5M | $7M | $9M | $9M | $9M | $6M | $4M | $3M | $6M | $5M | |
| Current Liabilities | $36M | $10M | $7M | $9M | $12M | $12M | $11M | $9M | $8M | $6M | $8M | $6M | |
| Capital Leases | $1M | $0 | $66.8K | · | $918.6K | $2M | $3M | · | · | · | · | · | |
| Total Liabilities | $37M | $47M | $7M | $9M | $13M | $15M | $14M | $9M | $9M | $7M | $8M | $6M | |
| Common Stock | $28.0K | $1.0K | $64.4K | $54.4K | $52.3K | $49.0K | $43.5K | $43.2K | $34.4K | $23.2K | $19.0K | $18.9K | |
| Paid-in Capital | $371M | $2M | $495M | $462M | $454M | $438M | $413M | $406M | $272M | $154M | $128M | $125M | |
| Retained Earnings | $-172M | $-18M | $-456M | $-420M | $-373M | $-309M | $-258M | $-201M | $-152M | $-119M | $-87M | $-74M | |
| Stockholders' Equity | $203M | $-15M | $38M | $43M | $82M | $128M | $154M | $205M | $120M | $35M | $40M | $51M | |
| Liabilities + Equity | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Shares Outstanding | 27,556,767 | 1,018,604 | 64,393,744 | 54,377,798 | 52,313,894 | 49,017,622 | 43,466,933 | 43,160,751 | 34,359,799 | 23,250,023 | 19,050,204 | 18,939,838 |
Flujo de Efectivo 11
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $5M | $4M | $4M | $6M | $7M | $6M | $5M | $4M | $3M | $2M | $2M | |
| Deferred Tax | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | $7M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-72M | $-31M | $-35M | $-46M | $-57M | $-39M | $-52M | $-43M | $-30M | $-30M | $-8M | $-4M | |
| CapEx | $919.0K | $10.0K | $21.4K | $84.2K | $14.9K | $68.5K | $144.9K | $125.6K | $294.1K | $704.2K | $268.6K | $212.6K | |
| Investing Cash Flow | $-73M | $20.0K | $-21.4K | $-84.2K | $-14.9K | $-68.5K | $-144.9K | $-125.6K | $-294.1K | $-704.2K | $-268.6K | · | |
| Stock Issued | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Net Stock Activity | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Financing Cash Flow | $323M | $5.4K | $29M | $4M | $11M | $18M | $412.9K | $129M | $114M | $24M | $114.1K | · | |
| Net Change in Cash | $179M | $-31M | $-6M | $-42M | $-47M | $-21M | $-52M | $86M | $84M | $-7M | $-8M | $53M | |
| Free Cash Flow | $-72M | $-31M | $-35M | $-47M | $-58M | $-39M | $-52M | $-43M | $-30M | $-30M | $-9M | $-4M |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| Net Margin | -1419.6% | · | -368994.2% | -62251.7% | -5469.0% | -502.1% | · | · | · | -171945.1% | -63.6% | -74.0% | |
| Pretax Margin | -1401.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| ROA | -111.6% | -134.3% | -76.0% | -63.9% | -53.5% | -32.8% | -30.2% | -28.1% | -38.9% | -70.0% | -24.2% | -35.6% | |
| ROE | -90.0% | -1888.5% | -86.9% | -102.6% | -71.2% | -38.3% | -36.0% | -22.8% | -42.9% | -84.0% | -28.0% | -41.4% | |
| ROIC | -76.2% | · | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 | 11.1 | 14.8 | 24.2 | 15.6 | 6.4 | 6.1 | 8.7 | |
| Quick Ratio | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 | 11.0 | 14.4 | 24.0 | 15.2 | 6.3 | 6.0 | 8.5 |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | 0.0 | 0.0 | 0.1 | · | · | · | 0.0 | 0.4 | 0.5 | |
| Receivables Turnover | 1.2 | · | · | · | · | · | · | · | · | · | · | · |
Tasas de Crecimiento 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -86.7% | -93.5% | -88.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 424.9% | · | -90.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.3% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| Net Income TTM | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| Market Cap | $327M | $1.61B | $15.20B | $16.48B | $7.53B | $18.43B | $22.99B | $40.87B | $57.69B | $14.18B | $10.90B | $13.64B | |
| P/E | -24.2 | -42.4 | -406.9 | -340.4 | -117.1 | -335.7 | -394.8 | -1262.7 | -2238.7 | -813.3 | -805.6 | -1200.0 | |
| P/S | 30.1 | · | 1519692.4 | 219686.3 | 6495.4 | 1813.5 | · | · | · | 766622.4 | 542.9 | 907.5 | |
| P/B | 1.6 | 303.4 | 395.6 | 383.8 | 92.3 | 143.7 | 149.1 | 198.9 | 481.9 | 401.8 | 269.2 | 268.4 | |
| P / Tangible Book | 1.6 | · | 395.6 | 383.8 | 92.3 | 143.7 | · | · | · | · | · | · | |
| P / Cash Flow | -4.6 | -51.8 | -435.7 | -354.7 | -131.0 | -469.7 | -442.3 | -943.3 | -1938.0 | -477.0 | -1322.1 | -3185.0 | |
| P / FCF | -4.5 | -51.8 | -435.4 | -354.0 | -131.0 | -468.8 | -441.1 | -940.5 | -1919.0 | -466.0 | -1280.4 | -3034.3 | |
| Earnings Yield | -4.1% | -2.4% | -0.25% | -0.29% | -0.85% | -0.30% | -0.25% | -0.08% | -0.04% | -0.12% | -0.12% | -0.08% |
Estado de resultados 13
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | $0 | · | |
| R&D Expense | $19M | $18M | $106M | $20M | $12M | $11M | $233.2K | $2M | $6M | $6M | $5M | $5M | $4M | $5M | $6M | $5M | |
| SG&A Expense | $9M | $8M | $9M | $6M | $9M | $4M | $5M | $4M | $4M | $5M | $4M | $5M | $5M | $6M | $5M | $4M | |
| Operating Expenses | $28M | $26M | $114M | $26M | $21M | $14M | $7M | $11M | $10M | $11M | $10M | $10M | $9M | $11M | $11M | $9M | |
| Operating Income | $-26M | $-25M | $-103M | $-26M | $-21M | $-14M | $-7M | $-11M | $-10M | $-11M | $-10M | $-10M | $-9M | $-11M | $-11M | $-9M | |
| Other Non-op | $2M | $1M | · | $1M | $-760.0K | $-924.0K | $110.1K | $1M | · | · | $512.2K | $611.0K | · | · | · | · | |
| Income Tax | $0 | $0 | $2M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-25M | $-23M | $-23M | $-25M | $-22M | $-15M | $-7M | $-10M | $-10M | $-11M | $-9M | $-9M | $-8M | $-10M | $-10M | $-9M | |
| EPS (Basic) | · | · | · | · | · | $-0.04 | $-0.11 | $-0.15 | $-0.16 | $-0.17 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| EPS (Diluted) | · | · | · | · | · | · | $-0.24 | $-0.15 | $-0.16 | $-0.04 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| Shares (Basic) | · | · | · | · | · | 64,522,257 | -128,947,790 | 64,483,958 | 64,483,848 | 64,457,233 | -125,633,555 | 64,349,709 | 64,276,184 | 60,350,127 | -104,631,509 | 52,423,944 | |
| Shares (Diluted) | · | · | · | · | · | · | -129,012,814 | 64,483,958 | 64,483,848 | 64,522,257 | -129,740,661 | 64,349,709 | 64,276,184 | 64,457,233 | -104,631,509 | 52,423,944 | |
| EBITDA | $-26M | · | · | $-26M | $-21M | $-2M | · | $-11M | $-10M | $-11M | · | $-10M | $-9M | $-11M | · | $-9M |
Balance general 21
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $172M | $189M | $213M | $133M | $153M | $6M | $11M | $14M | $22M | $31M | $42M | $49M | $58M | $65M | $48M | $52M | |
| Receivables | $0 | $0 | $18M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $7M | $6M | $5M | $1M | $2M | $378.0K | $371.3K | $1M | $1M | $2M | $2M | $3M | $2M | $3M | $3M | $2M | |
| Other Current Assets | $7M | $6M | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $179M | $196M | $237M | $135M | $154M | $6M | $11M | $16M | $24M | $33M | $44M | $52M | $60M | $68M | $51M | $54M | |
| PP&E (Net) | $876.0K | $929.0K | $846.0K | $782.0K | $193.0K | · | · | · | · | · | · | $133.0K | $167.9K | $200.7K | · | $288.1K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | · | $2M | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Accounts Payable | · | · | · | · | · | $104.7K | $329.3K | $581.8K | $950.8K | $755.5K | $868.1K | $329.9K | $241.5K | $480.2K | $970.2K | $852.1K | |
| Accrued Liabilities | $7M | $4M | $16M | $9M | $8M | $3M | $5M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $7M | $6M | |
| Current Liabilities | $19M | $14M | $36M | $20M | $17M | $3M | $6M | $4M | $4M | $5M | $7M | $6M | $7M | $7M | $9M | $8M | |
| Capital Leases | $966.0K | $1M | $1M | $1M | $1M | · | · | · | · | · | $66.8K | $262.1K | $448.8K | · | · | $95.6K | |
| Total Liabilities | $20M | $15M | $37M | $22M | $18M | $3M | $6M | $4M | $4M | $5M | $7M | $7M | $7M | $7M | $9M | $8M | |
| Common Stock | $28.0K | $28.0K | $28.0K | $14.0K | $14.0K | $64.5K | $64.5K | $64.5K | $64.5K | $64.5K | $64.4K | $64.4K | $64.3K | $64.2K | $54.4K | $52.4K | |
| Paid-in Capital | $379M | $375M | $371M | $192M | $190M | $500M | $500M | $498M | $497M | $496M | $495M | $494M | $493M | $492M | $462M | $457M | |
| Retained Earnings | $-220M | $-195M | $-172M | $-79M | $-55M | $-497M | $-494M | $-487M | $-477M | $-467M | $-456M | $-447M | $-438M | $-430M | $-420M | $-409M | |
| Stockholders' Equity | $163M | $184M | $203M | $117M | $139M | $3M | $5M | $11M | $20M | $29M | $38M | $47M | $55M | $62M | $43M | $48M | |
| Liabilities + Equity | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Shares Outstanding | 27,756,044 | 27,571,935 | 27,556,767 | 13,892,516 | 13,892,562 | 64,532,091 | 64,483,958 | 64,483,958 | 64,483,958 | 64,450,835 | 64,393,744 | 64,368,843 | 64,313,333 | 64,245,224 | 54,377,798 | 52,423,944 |
Flujo de Efectivo 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $2M | $6M | $1M | $1M | $1M | $1M | $1M | $908.4K | $887.8K | $858.1K | $870.2K | $899.2K | $914.0K | |
| Restructuring | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-19M | $-9M | $-27M | $-18M | $-22M | $-11M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $-12M | $-8M | $-9M | |
| CapEx | $13.0K | $147.0K | $193.0K | $586.0K | $140.0K | $0 | $0 | $0 | $2.5K | $7.4K | $801 | $7.9K | $10.5K | $2.2K | $1 | $2.5K | |
| Investing Cash Flow | $2M | $-8M | $-72M | $-586.0K | $-140.0K | $0 | $30.0K | $0 | $-2.5K | $-7.4K | $-801 | $-7.9K | $-10.5K | $-2.2K | $-1 | $-2.5K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $29M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $29M | · | · | |
| Financing Cash Flow | $136.0K | $-7M | $179M | $-1M | $147M | $-1M | $0 | $0 | $500 | $4.9K | $999 | $61.6K | $20.1K | $29M | · | · | |
| Net Change in Cash | $-18M | $-24M | $80M | $-19M | $123M | $-12M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $17M | $-4M | $-9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-11M | · | · | · | $-12M | · | · |
Rentabilidad 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.6% | · | · | -32.0% | -24.0% | -11.7% | · | -28.5% | -23.4% | -20.8% | · | -16.9% | -13.0% | -13.8% | · | -10.4% | |
| ROE | -16.4% | · | · | -38.4% | -27.4% | -14.5% | · | -33.9% | -27.0% | -23.6% | · | -19.4% | -14.9% | -15.9% | · | -11.8% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | · | · | 6.6 | 9.2 | 2.3 | · | 3.6 | 5.5 | 6.3 | · | 8.1 | 9.2 | 10.1 | · | 6.9 | |
| Quick Ratio | 9.3 | · | · | 6.6 | 9.1 | 2.1 | · | 3.3 | 5.1 | 5.9 | · | 7.7 | 8.8 | 9.6 | · | 6.7 |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-96M | $-93M | · | $-71M | $-57M | $-46M | · | $-40M | $-38M | $-39M | · | $-36M | $-40M | $-47M | · | $-54M | |
| Market Cap | $500M | · | · | $165M | $224M | $1.36B | · | $1.10B | $1.81B | $19.34B | · | $9.66B | $11.19B | $8.09B | · | $2.88B | |
| P/E | -36.7 | -37.5 | · | -24.3 | -32.9 | -42.9 | · | -34.7 | -59.6 | -625.0 | · | -250.0 | -245.1 | -146.5 | · | -53.4 | |
| P/B | 3.1 | · | · | 1.4 | 1.6 | 401.5 | · | 96.4 | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Tangible Book | 3.1 | 2.8 | · | 1.4 | 1.6 | 401.5 | · | 96.4 | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Cash Flow | · | · | · | · | · | -265.4 | · | · | · | -1839.9 | · | · | · | -697.4 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -1838.6 | · | · | · | -697.3 | · | · | |
| Earnings Yield | -2.7% | -2.7% | · | -4.1% | -3.0% | -2.3% | · | -2.9% | -1.7% | -0.16% | · | -0.40% | -0.41% | -0.68% | · | -1.9% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $11M | — | $10.0K | $75.0K | $1M |
| Margen Operativo % | -1407.5% | — | -392752.9% | -63204.4% | -5470.7% |
| Beneficio neto | $-154M | $-38M | $-37M | $-47M | $-63M |
| EPS Diluido | — | $-0.59 | $-0.58 | $-0.89 | $-1.23 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 |
| Ratio Rápido | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-72M | $-31M | $-35M | $-47M | $-58M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 82 declarantes · $470.5M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 35 (+21 vs trimestre anterior) | 12 (+2 vs trimestre anterior) | 14 (-3 vs trimestre anterior) | 15 (+7 vs trimestre anterior) | +3.5M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $51 011 496 | 2 833 972 | 10,84% | Acciones |
| BVF INC/IL | $49 477 734 | 2 748 763 | 10,52% | Acciones |
| Fairmount Funds Management LLC | $49 461 588 | 2 747 866 | 10,51% | Acciones |
| Venrock Adviser, LLC | $38 404 368 | 2 133 576 | 8,16% | Acciones |
| Logos Global Management LP | $34 200 000 | 1 900 000 | 7,27% | Acciones |
| FCPM III SERVICES B.V. | $30 201 336 | 1 677 852 | 6,42% | Acciones |
| Balyasny Asset Management L.P. | $29 932 506 | 1 662 917 | 6,36% | Acciones |
| Vestal Point Capital, LP | $29 340 000 | 1 630 000 | 6,24% | Acciones |
| Opaleye Management Inc. | $23 748 318 | 1 319 351 | 5,05% | Acciones |
| TANG CAPITAL MANAGEMENT LLC | $20 880 000 | 1 160 000 | 4,44% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $13 819 590 | 767 755 | 2,94% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $7 269 462 | 403 859 | 1,55% | Acciones |
| JENNISON ASSOCIATES LLC | $6 813 126 | 378 507 | 1,45% | Acciones |
| RTW INVESTMENTS, LP | $6 711 408 | 372 856 | 1,43% | Acciones |
| NEXTBio Capital Management LP | $6 711 408 | 372 856 | 1,43% | Acciones |
| Remedium Capital Partners, LLC | $6 502 500 | 361 250 | 1,38% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $6 056 873 | 336 411 | 1,29% | Acciones |
| VANGUARD GROUP INC | $5 984 722 | 504 614 | 1,27% | Acciones |
| STATE STREET CORP | $5 680 566 | 315 587 | 1,21% | Acciones |
| AMERIPRISE FINANCIAL INC | $5 446 224 | 302 568 | 1,16% | Acciones |
| Point72 Asset Management, L.P. | $5 400 000 | 300 000 | 1,15% | Acciones |
| PERCEPTIVE ADVISORS LLC | $3 724 956 | 206 942 | 0,79% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3 398 454 | 188 803 | 0,72% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $3 363 732 | 186 874 | 0,71% | Acciones |
| STEMPOINT CAPITAL LP | $3 282 876 | 182 382 | 0,70% | Acciones |
| UBS Group AG | $3 061 674 | 170 093 | 0,65% | Acciones |
| Exome Asset Management LLC | $2 299 842 | 127 769 | 0,49% | Acciones |
| SECTORAL ASSET MANAGEMENT INC | $2 183 400 | 121 300 | 0,46% | Acciones |
| Woodline Partners LP | $1 700 784 | 94 488 | 0,36% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 354 050 | 75 225 | 0,29% | Acciones |
| Burkehill Global Management, LP | $1 332 000 | 74 000 | 0,28% | Acciones |
| Blackstone Inc. | $1 127 646 | 62 647 | 0,24% | Acciones |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1 063 872 | 59 104 | 0,23% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $914 832 | 50 824 | 0,19% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $904 644 | 50 258 | 0,19% | Acciones |
| Nuveen, LLC | $857 322 | 47 629 | 0,18% | Acciones |
| Stonepine Capital Management, LLC | $720 000 | 40 000 | 0,15% | Acciones |
| RHUMBLINE ADVISERS | $458 766 | 25 487 | 0,10% | Acciones |
| MOORE CAPITAL MANAGEMENT, LP | $450 000 | 25 000 | 0,10% | Acciones |
| Squarepoint Ops LLC | $434 988 | 24 166 | 0,09% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $410 490 | 22 805 | 0,09% | Acciones |
| TWO SIGMA ADVISERS, LP | $385 450 | 32 500 | 0,08% | Acciones |
| WELLS FARGO & COMPANY/MN | $354 600 | 19 700 | 0,08% | Acciones |
| ADAR1 Capital Management, LLC | $328 950 | 18 275 | 0,07% | Acciones |
| Virtus Investment Advisers, LLC | $328 644 | 18 258 | 0,07% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $319 590 | 17 755 | 0,07% | Acciones |
| BANK OF MONTREAL /CAN/ | $247 806 | 13 767 | 0,05% | Acciones |
| MetLife Investment Management, LLC | $230 040 | 12 780 | 0,05% | Acciones |
| Bank of New York Mellon Corp | $224 892 | 12 494 | 0,05% | Acciones |
| BANK OF AMERICA CORP /DE/ | $223 452 | 12 414 | 0,05% | Acciones |
| Persistent Asset Partners Ltd | $197 424 | 10 968 | 0,04% | Acciones |
| XTX Topco Ltd | $190 152 | 10 564 | 0,04% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $178 218 | 9 901 | 0,04% | Acciones |
| CITIGROUP INC | $160 110 | 8 895 | 0,03% | Acciones |
| Invesco Ltd. | $154 980 | 8 610 | 0,03% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $136 800 | 7 600 | 0,03% | Acciones |
| BlackRock, Inc. | $119 484 | 6 638 | 0,03% | Acciones |
| Police & Firemen's Retirement System of New Jersey | $114 642 | 6 369 | 0,02% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $84 600 | 4 700 | 0,02% | Acciones |
| NORTHERN TRUST CORP | $61 128 | 3 396 | 0,01% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $59 454 | 3 303 | 0,01% | Acciones |
| MARSHALL WACE, LLP | $59 130 | 3 285 | 0,01% | Acciones |
| BARCLAYS PLC | $54 648 | 3 036 | 0,01% | Acciones |
| Vanguard Global Advisers, LLC | $48 852 | 2 714 | 0,01% | Acciones |
| Legal & General Group Plc | $37 746 | 2 097 | 0,01% | Acciones |
| Tower Research Capital LLC (TRC) | $31 500 | 1 750 | 0,01% | Acciones |
| Russell Investments Group, Ltd. | $31 068 | 1 726 | 0,01% | Acciones |
| ROYAL BANK OF CANADA | $12 000 | 661 | 0,00% | Acciones |
| US BANCORP \DE\ | $7 254 | 403 | 0,00% | Acciones |
| Parallel Advisors, LLC | $4 752 | 264 | 0,00% | Acciones |
| PRICE T ROWE ASSOCIATES INC /MD/ | $4 488 | 249 312 | 0,00% | Acciones |
| Allworth Financial LP | $2 898 | 161 | 0,00% | Acciones |
| Sterling Capital Management LLC | $1 368 | 76 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $1 224 | 68 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $1 206 | 67 | 0,00% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $900 | 50 | 0,00% | Acciones |
| MORGAN STANLEY | $792 | 44 | 0,00% | Acciones |
| Fortitude Family Office, LLC | $720 | 40 | 0,00% | Acciones |
| Quarry LP | $522 | 29 | 0,00% | Acciones |
| OSAIC HOLDINGS, INC. | $468 | 26 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $378 | 21 | 0,00% | Acciones |
| NATIONAL BANK OF CANADA /FI/ | $54 | 3 | 0,00% | Acciones |
Informantes de la empresa 33 insiders · 15 directivos · 18 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Joshua T Brumm | Chief Executive Officer | 22 de junio de 2026 S | 281 212 | 0 | 1 | $-761 067 |
| Harout Semerjian | Chief Executive Officer | 12 de enero de 2024 A | 25 000 | 0 | 0 | $0 |
| Richard William Scalzo | Chief Financial Officer | 22 de junio de 2026 S | 20 298 | 0 | 1 | $-20 005 |
| Brian M. Hahn | SVP Finance, CFO | 12 de enero de 2024 A | 53 143 | 0 | 0 | $0 |
| Jonathan Mcneill | President and COO | 22 de junio de 2026 S | 139 158 | 0 | 1 | $-369 677 |
| Jan Pinkas | Chief Scientific Officer | 22 de junio de 2026 S | 22 239 | 0 | 1 | $-23 171 |
| Barbara Harlin Bispham | General Counsel and Corporate Secretary. | 22 de junio de 2026 S | 19 330 | 0 | 1 | $-21 912 |
| Ellie Eunkyung Im | Chief Medical Officer | 22 de junio de 2026 S | 22 069 | 0 | 1 | $-21 930 |
| Ryan Lynch | Treasurer, Senior Vice President of Finance and Chief Accounting Officer. | 22 de junio de 2026 S | 13 871 | 0 | 1 | $-8 365 |
| Bruce S Johnson | SVP & Chief Commercial Officer | 12 de enero de 2024 A | 138 980 | 0 | 0 | $0 |
| Chinmaya Rath | SVP and Chief Business Officer | 12 de enero de 2024 A | — | 0 | 0 | $0 |
| Edwin Rock | Chief Medical Officer | 12 de enero de 2024 A | 375 403 | 0 | 0 | $0 |
| Armand Girard | SVP, Chief Business Officer | 11 de noviembre de 2022 P | 29 161 | 0 | 0 | $0 |
| John L. Magnani | SVP of Research, CSO | 11 de noviembre de 2022 P | 366 078 | 0 | 0 | $0 |
| Helen M. Thackray | SVP Clinical Development, CMO | 20 de enero de 2021 A | 183 115 | 0 | 0 | $0 |
| Alexandra Balcom | Consejero | 2 de junio de 2026 A | — | 0 | 0 | $0 |
| Susan Moran | Consejero | 2 de junio de 2026 A | — | 0 | 0 | $0 |
| Jonathan Violin | Consejero | 2 de junio de 2026 A | — | 0 | 0 | $0 |
| David Charles Lubner | Consejero | 2 de junio de 2026 A | — | 0 | 0 | $0 |
| Rachel K. King | Consejero | 29 de diciembre de 2023 A | 511 860 | 0 | 0 | $0 |
| Mark Alan Goldberg | Consejero | 29 de diciembre de 2023 A | 20 244 | 0 | 0 | $0 |
| Patricia S Andrews | Consejero | 29 de diciembre de 2023 A | 58 608 | 0 | 0 | $0 |
| Scott Koenig | Consejero | 1 de junio de 2023 M | 36 750 | 0 | 0 | $0 |
| Scott Thomas Jackson | Consejero | 19 de mayo de 2023 A | 5 250 | 0 | 0 | $0 |
| Timothy R Pearson | Consejero | 19 de mayo de 2023 A | 24 650 | 0 | 0 | $0 |
| JUNIUS DANIEL M | Consejero | 19 de mayo de 2023 A | 93 250 | 0 | 0 | $0 |
| James M Barrett | Consejero | 18 de mayo de 2018 A | 4 995 664 | 0 | 0 | $0 |
| John J. Baldwin | Consejero | 29 de junio de 2016 M | 1 210 | 0 | 0 | $0 |
| Franklin H Top JR | Consejero | 17 de mayo de 2016 A | 12 294 | 0 | 0 | $0 |
| Michael A Henos | Consejero | 15 de julio de 2015 A | 469 454 | 0 | 0 | $0 |
| William M. Gust | Consejero | 15 de enero de 2014 C | 409 947 | 0 | 0 | $0 |
| Scott D. Sandell | Propietario del 10% | 26 de enero de 2023 S | 2 237 196 | 0 | 0 | $0 |
| Peter J Barris | Propietario del 10% | 10 de mayo de 2018 X | 4 995 664 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 4 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Harwin, Tomas Kiselak ×3 presentaciones | 20 de julio de 2026 | 16,52% | Enmienda | Inversión pasiva | SEC |
| Adage Capital Management, L.P., Robert Atchinson, Phillip Gross ×2 presentaciones | 20 de junio de 2025 | 0,37% | Enmienda | — | SEC |
| 8 de mayo de 2024 | — | Presentación inicial | — | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates 13, L.P., NEA Partners 13, L.P., NEA 13 GP, LTD, Anthony A. Florence, Jr, Mohamad H. Makhzoumi, Scott D. Sandell ×4 presentaciones | 29 de febrero de 2024 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 10 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,08% | 73 362 SH | 8 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,02% | 197 875 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 23 282 SH | 8 de agosto de 2026 | Diario |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 15 612 NS | 31 de mayo de 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 529 441 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 124 281 SH | 8 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 83 801 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 661 946 SH | 8 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 832 SH | 8 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,00% | 39 408 SH | 8 de agosto de 2026 | Diario |